ORAL FORMULATION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID AND METHOD FOR PREPARING SAME

The present invention relates to an oral formulation comprising a high content of an API selected from 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof. The oral formulation according to the present invention has a high content and excellent...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Ree Sun, JANG, Joomyung, SEO, Jin A, YOO, Seok Cheol
Format Patent
LanguageEnglish
French
Korean
Published 09.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to an oral formulation comprising a high content of an API selected from 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof. The oral formulation according to the present invention has a high content and excellent physical properties by comprising a fluidizing agent from among excipients, and thus can have increased economic efficiency and convenience of administration. La présente invention concerne une formulation orale comprenant une teneur élevée en une API choisie parmi un acide 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylique ou un sel pharmaceutiquement acceptable de celui-ci. La formulation orale de la présente invention a une teneur élevée et d'excellentes propriétés physiques grâce à l'inclusion d'un agent de fluidisation parmi les excipients et peut ainsi avoir une efficacité économique et une commodité d'administration accrues. 본 발명은 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산 또는 이의 약학적으로 허용가능한 염에서 선택되는 API를 고함유량으로 포함하는 경구용 제제에 관한 것이다. 본 발명에 따른 경구용 제제는 부형제 중 유동화제를 포함함으로써 높은 함량을 가지고 물리적 성질이 우수한 특징을 가지고 있으므로, 경제성, 복용편의성이 증대될 수 있다.
Bibliography:Application Number: WO2021KR17843